SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (6119)3/24/1998 11:42:00 PM
From: Zebra 365  Read Replies (3) of 23519
 
<<<IMO the price already reflects Viagra approval (at this point nobody thinks Viagra won't get approval). IMO the extremely (and I mean extremely) small chance that Viagra approval will be delayed gives the stock price some serious upside potential.>>>

I most vehemently disagree that the upside potential of this stock is in the delay of Viagra approval. When this stock hit 40 back in October I had a decision, to sell or ride it down and back up. In retrospect my decision was wrong because I'd be much better trading out then back in. So.....

Point is that then and now I saw a much greater upside here, knowing what I know about ED, and its myriad causes and the local vs systemic issue. Viagra was nothing new then or now. IMHO the worst thing that could happen to this stock now is for a delay of Viagra approval to occur.

Lets get Viagra on the market, go head-to-head and sort this market out. This stock is being hit by two uncertainties, lets cut it to one and move on. I've seen the scenario before for drugs, when the company make the upside news, the media will make the downside news. Been there, done that. Watch this story unfold and remember my forecast, the circus surrounding Viagra will prove to be its own undoing.

Zebra
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News